Effects of estrogenic hormones on early development of Xenopus laevis.
Many chemicals released into the environment have estrogenic activity and can disrupt animal development and the function of endocrine systems. In order to study the effects of estrogens on aquatic animals, we examined the effects of certain estrogens on early development in Xenopus laevis. X. laevis embryos were kept in water containing 10(-10), 10(-9), 10(-7), 10(-6), and 10(-5) M 17 beta-estradiol (E2); 17 alpha-estradiol; diethylstilbestrol (DES); 10(-5) M progesterone (P); or dihydrotestosterone (DHT) beginning at developmental stage 3. Survival rates of the embryos developed in water containing 10(-10)-10(-6) M E2 or DES, all concentrations of 17 alpha-estradiol, and 10(-5) M P or DHT, which were over 70% after stage 48, whereas the rates of the embryos treated with 10(-5) M E2 and DES decreased remarkably after stage 27 and all embryos were dead by stages 42 and 32, respectively. Embryos treated with 10(-5) M E2 showed malformations of the head and abdomen and suppressed organogenesis, including crooked vertebrae at stage 38; the head was smaller and the abdomen was larger than in the controls. Similar effects were observed in embryos developed in 10(-5) M DES but not in 10(-5) M 17 alpha-estradiol, P, or DHT. After 10(-5) M E2 treatment, abnormalities were induced only when the treatment was started before stage 39. However, on day 30 after fertilization, the stage of the embryos treated with 10(-6) M E2 was more progressed than that of the controls. Estrogen receptor (ER 4) mRNA was examined in eggs, embryos, and adult female liver by reverse-transcription polymerase chain reaction. ER4 mRNA was expressed in adult liver, unfertilized and fertilized eggs, and embryos, but ER3 mRNA was not expressed. ER4 mRNA in 10(-6) and 10(-5) M E2-treated embryos showed different expression patterns, which may result from the diverse developmental effects of E2. The present results demonstrate that 10(-5) M E2 and DES induced embryo death and malformations and that ER may be involved in the induction of various developmental defects in X. laevis embryos.
Nishimura
N
N
Graduate School of Integrated Science, Yokohama City University, Japan.
Fukazawa
Y
Y
Uchiyama
H
H
Iguchi
T
T
D000005:Abdomen / Q000002:abnormalities* / Q000196:embryology; D000014:Abnormalities, Drug-Induced; D000818:Animals; D017931:DNA Primers; D013196:Dihydrotestosterone / Q000633:toxicity*; D004625:Embryo, Nonmammalian / Q000187:drug effects*; D004967:Estrogens / Q000633:toxicity*; D005260:Female; D006257:Head / Q000002:abnormalities* / Q000196:embryology; D007814:Larva; D008099:Liver / Q000378:metabolism; D008297:Male; D009024:Morphogenesis; D016133:Polymerase Chain Reaction; D011374:Progesterone / Q000633:toxicity*; D012333:RNA, Messenger / Q000378:metabolism; D011960:Receptors, Estrogen / Q000235:genetics / Q000378:metabolism; D015996:Survival Rate; D014982:Xenopus laevis / Q000196:embryology*
D017931:DNA Primers; D004967:Estrogens; D012333:RNA, Messenger; D011960:Receptors, Estrogen; D013196:Dihydrotestosterone; D011374:Progesterone